Related Experiment Video
Updated: Jul 14, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Expression of ral GTPases, their effectors, and activators in human bladder cancer
Steven Christopher Smith1, Gary Oxford, Alexander S Baras
1Department of Molecular Physiology, University of Virginia, Charlottesville, Virginia 22908, USA.
Purpose:
The Ral family of small G proteins has been implicated in tumorigenesis, invasion, and metastasis in in vitro and animal model systems; however, a systematic evaluation of the state of activation, mutation, or expression of these GTPases has not been reported in any tumor type.
Experimental Design:
We determined the activation state of the RalA and RalB paralogs in 10 bladder cancer cell lines with varying Ras mutation status. We sequenced RalA and RalB cDNAs from 20 bladder cancer cell lines and functionally evaluated the mutations found. We determined the expression of Ral, Ral activators, and Ral effectors on the level of mRNA or protein in human bladder cancer cell lines and tissues.
Results:
We uncovered one E97Q substitution mutation of RalA in 1 of 20 cell lines tested and higher Ral activation in cells harboring mutant HRAS. We found overexpression of mRNAs for RalA and Aurora-A, a mitotic kinase that activates RalA, in bladder cancer (both P < 0.001), and in association with tumors of higher stage and grade. RalBP1, a canonical Ral effector, mRNA and protein was overexpressed in bladder cancer (P < 0.001), whereas Filamin A was underexpressed (P = 0.004). We determined that RalA mRNA levels correlated significantly with protein levels (P < 0.001) and found protein overexpression of both GTPases in homogenized invasive cancers. Available data sets suggest that RalA mRNA is also overexpressed in seminoma, glioblastoma, and carcinomas of the liver, pancreas, and prostate.
Conclusion:
These findings of activation and differential expression of RalA and RalB anchor prior work in model systems to human disease and suggest therapeutic strategies targeting both GTPases in this pathway may be beneficial.
Insights
This study reveals RalA and RalB GTPase activation and differential expression in bladder cancer, linking prior model system findings to human disease and suggesting potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- GTPase Signaling
Background:
- The Ral family of small G proteins (GTPases) is implicated in cancer progression.
- Previous studies suggested roles in tumorigenesis, invasion, and metastasis in model systems.
- A comprehensive analysis of Ral GTPase activation and expression in human tumors was lacking.
Purpose of the Study:
- To systematically evaluate the activation state, mutation status, and expression levels of RalA and RalB in bladder cancer.
- To correlate these findings with tumor characteristics and known oncogenic pathways.
- To establish a link between in vitro/animal model findings and human bladder cancer.
Main Methods:
- Assessed RalA and RalB activation in 10 bladder cancer cell lines with varying Ras mutation status.
- Sequenced RalA and RalB cDNAs from 20 bladder cancer cell lines and functionally characterized mutations.
- Quantified mRNA and protein expression of Ral GTPases, activators (e.g., Aurora-A), and effectors (e.g., RalBP1, Filamin A) in cell lines and tissues.
Main Results:
- Identified one RalA E97Q mutation in 20 cell lines; observed higher Ral activation in cells with mutant HRAS.
- Found significant overexpression of RalA and Aurora-A mRNA in bladder cancer, correlating with higher stage and grade.
- Demonstrated overexpression of RalBP1 (mRNA/protein) and underexpression of Filamin A in bladder cancer; confirmed RalA mRNA-protein correlation and overexpression of both GTPases in invasive cancers.
Conclusions:
- The findings demonstrate RalA and RalB activation and differential expression in human bladder cancer.
- These results connect prior model system data to human disease.
- Targeting the Ral GTPase pathway presents a potential therapeutic strategy for bladder cancer.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins, also known...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
